Anterior Uveitis with Posterior Synechia and Iris Atrophy Following Implantation of a Phakic Intraocular Lens
Authors Mohammadpour M, Mazloumi M, Khorrami-Nejad M
Received 23 March 2020
Accepted for publication 14 May 2020
Published 28 May 2020 Volume 2020:13 Pages 225—228
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Mehrdad Mohammadpour,1 Mehdi Mazloumi,2 Masoud Khorrami-Nejad1,3
1Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; 2Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA; 3School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Correspondence: Mehdi Mazloumi
Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA
Tel +1 2673577861
Purpose: To describe a case with acute postoperative uveitis, posterior synechia and iris atrophy following iris-claw phakic intraocular lens (pIOL) implantation.
Methods: A case report.
Results: A 26-year-old man with high myopia had implantation of a − 14.0 diopter, foldable, iris-claw Artiflex (model 401) anterior chamber pIOL (Ophtec B.V.) in both eyes. On the third postoperative day, the patient had significant postoperative inflammation in the left eye and received topical steroids and mydriatic eye drops. On the fifth postoperative day, the right eye had a round pupil and centered pIOL, but the left eye had an atrophic iris and dilated pupil with significant posterior synechias over the inferior half of the pupil. Despite intensive topical steroid application, the synechias remained one year after surgery.
Conclusion: Severe uveitis with posterior synechia can occur after iris-claw pIOL implantation. We hypothesized that excessive iris tissue enclavation in the pIOLs haptics and large iridotomies may be an associated factor.
Keywords: phakic intraocular lenses, anterior uveitis, posterior synechia, iris atrophy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]